Williams Cos Inc's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Williams Cos Inc reported revenue of $11.9B (+13.8% year on year) and net income of $2.8B (+18.0% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Revenues | $11.9B | $10.5B | $10.9B | $11.0B |
| Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization | $2.2B | $2.1B | $2.0B | $3.5B |
| Operating and maintenance expenses | $2.3B | $2.2B | $2.0B | $1.8B |
| Depreciation, depletion, and amortization expenses | $2.3B | $2.2B | $2.1B | $2.0B |
| General and administrative expenses | $721.0M | — | — | — |
| Impairment or write-off of certain assets (Note 16) | $212.0M | — | — | $0 |
| Gain on sale of business (Note 3) | $0 | $0 | ($129.0M) | — |
| Other (income) expense – net | ($7.0M) | ($60.0M) | ($30.0M) | $28.0M |
| Total costs and expenses | $7.8B | $7.2B | $6.6B | $7.9B |
| Operating income (loss) | $4.2B | $3.3B | $4.3B | $3.0B |
| Equity earnings (losses) | $760.0M | $560.0M | $589.0M | $637.0M |
| Other investing income (loss) – net | $42.0M | $343.0M | $108.0M | $16.0M |
| Interest expense | ($1.4B) | ($1.4B) | ($1.2B) | — |
| Gain (Loss) Related to Litigation Settlement | $0 | $0 | $534.0M | — |
| Other income (expense) – net | $69.0M | $108.0M | $99.0M | $18.0M |
| Income (loss) before income taxes | $3.6B | $3.0B | $4.4B | $2.5B |
| Less: Provision (benefit) for income taxes | $857.0M | $640.0M | $1.0B | $425.0M |
| Income (loss) from continuing operations | $2.8B | $2.3B | $3.4B | — |
| Net income | $2.8B | $2.3B | $3.3B | $2.1B |
| Less: Net income (loss) attributable to noncontrolling interests | $150.0M | $121.0M | $124.0M | $68.0M |
| Net income | $2.6B | $2.2B | $3.2B | $2.0B |
| Less: Preferred stock dividends | $3.0M | $3.0M | $3.0M | $3.0M |
| Net income (loss) available to common stockholders | $2.6B | $2.2B | $3.2B | $2.0B |
| Income (loss) from continuing operations | $2.6B | $2.2B | — | — |
| Income (loss) from discontinued operations (Note 1) | $0 | $0 | ($97.0M) | — |
| Income (Loss) from Continuing Operations, Per Basic Share | $2.14 | $1.82 | $2.69 | — |
| Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share | $0 | $0 | ($0.08) | — |
| Net income (loss) available to common stockholders - Basic | $2.14 | $1.82 | $2.61 | $1.68 |
| Weighted Average Number of Shares Outstanding, Basic | 1.2B | 1.2B | 1.2B | 1.2B |
| Income (Loss) from Continuing Operations, Per Diluted Share | $2.14 | $1.82 | $2.68 | — |
| Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share | $0 | $0 | ($0.08) | — |
| Net income (loss) available to common stockholders - Diluted | $2.14 | $1.82 | $2.60 | $1.67 |
| Weighted Average Number of Shares Outstanding, Diluted | 1.2B | 1.2B | 1.2B | 1.2B |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Revenues | $3.1B | $3.0B | $2.9B | $2.8B |
| Operating Costs and Expenses | $597.0M | — | $583.0M | $572.0M |
| Depreciation, depletion, and amortization | $592.0M | $584.0M | $564.0M | $605.0M |
| General and Administrative Expense | $180.0M | $193.0M | — | — |
| Taxes, Miscellaneous | $31.0M | $33.0M | — | — |
| Other Operating Income (Expense), Net | ($1.0M) | ($9.0M) | $14.0M | $13.0M |
| Total costs and expenses | $1.9B | $1.7B | $1.8B | $1.8B |
| Operating income (loss) | $1.2B | $1.3B | $1.1B | $945.0M |
| Interest expense | ($371.0M) | ($376.0M) | ($372.0M) | ($350.0M) |
| Public Utilities, Allowance for Funds Used During Construction, Additions | $17.0M | $12.0M | — | — |
| Other Nonoperating Income (Expense) | $32.0M | $26.0M | $21.0M | $16.0M |
| Net income (loss) | $1.1B | $1.2B | $929.0M | $757.0M |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $63.0M | $60.0M | $2.1B | $152.0M |
| Receivables, Net, Current | $2.1B | $1.9B | $1.7B | $2.7B |
| Inventories | $314.0M | $279.0M | $274.0M | $320.0M |
| Assets held for sale (Note 3) | $318.0M | — | — | — |
| Derivative assets | $209.0M | $267.0M | $239.0M | $323.0M |
| Other current assets and deferred charges | $256.0M | $192.0M | $195.0M | $279.0M |
| Total current assets | $3.2B | $2.7B | $4.5B | $3.8B |
| Investments | $4.6B | $4.1B | $4.6B | $5.1B |
| Property, Plant and Equipment, Net | $42.0B | $38.7B | $34.3B | $30.9B |
| Intangible assets – net | $6.8B | $7.2B | $7.6B | $7.4B |
| Regulatory assets, deferred charges, and other | $2.0B | $1.8B | $1.6B | $1.3B |
| Total assets | $58.6B | $54.5B | $52.6B | $48.4B |
| Accounts payable | $2.2B | $1.6B | $1.4B | $2.3B |
| Liabilities held for sale (Note 3) | $63.0M | — | — | — |
| Derivative Liability, Current | $135.0M | $164.0M | $105.0M | $316.0M |
| Other current liabilities | $1.6B | $1.4B | — | — |
| Commercial paper | $700.0M | $455.0M | $725.0M | $350.0M |
| Long-term debt due within one year | $1.3B | $1.7B | $2.3B | $627.0M |
| Total current liabilities | $6.1B | $5.3B | $5.8B | $4.9B |
| Long-term debt | $27.3B | $24.7B | $23.4B | $21.9B |
| Deferred income tax liabilities | $5.2B | $4.4B | $3.8B | $2.9B |
| Other Liabilities, Noncurrent | $232.0M | $255.0M | — | — |
| Regulatory liabilities, deferred income, and other | $5.0B | $5.3B | $4.7B | $4.7B |
| Preferred stock ($1 par value; 30 million shares authorized at December 31, 2025 and December 31, 2024; 35 thousand shares issued at December 31, 2025 and December 31, 2024) | 35.0M | 35.0M | 35.0M | 35.0M |
| Common stock ($1 par value; 1,470 million shares authorized at December 31, 2025 and December 31, 2024; 1,261 million shares issued at December 31, 2025 and 1,258 million shares issued at December 31, 2024) | 1.3B | 1.3B | 1.3B | 1.3B |
| Capital in excess of par value | $24.8B | $24.6B | $24.6B | $24.5B |
| Retained deficit | ($12.2B) | ($12.4B) | ($12.3B) | ($13.3B) |
| Accumulated other comprehensive income (loss) | $127.0M | $76.0M | $0 | ($24.0M) |
| Treasury stock, at cost (39 million shares at December 31, 2025 and December 31, 2024 of common stock) | -1.2B | -1.2B | -1.2B | -1.1B |
| Total stockholders’ equity | $12.8B | $12.4B | $12.4B | $11.5B |
| Noncontrolling interests in consolidated subsidiaries | $2.2B | $2.4B | $2.5B | $2.6B |
| Total equity | $15.0B | $14.8B | $14.9B | $14.0B |
| Total liabilities and equity | $58.6B | $54.5B | $52.6B | $48.4B |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $203.0M | $950.0M | $70.0M | $903.0M |
| Receivables, Net, Current | $2.0B | $1.7B | $1.5B | $1.6B |
| Inventories | $335.0M | $262.0M | $339.0M | $335.0M |
| Assets held for sale (Note 3) | $60.0M | $0 | — | — |
| Derivative assets | $159.0M | $172.0M | $157.0M | $202.0M |
| Other current assets and deferred charges | $398.0M | $260.0M | $225.0M | $218.0M |
| Total current assets | $3.1B | $3.3B | $2.3B | $3.2B |
| Investments | $4.5B | $4.5B | $4.2B | $4.2B |
| Property, plant, and equipment | $65.3B | $63.6B | $60.3B | $59.4B |
| Accumulated depreciation, depletion, and amortization | ($20.9B) | ($20.5B) | ($19.9B) | ($19.6B) |
| Property, plant, and equipment – net | $44.4B | $43.1B | $40.4B | $39.8B |
| Intangible assets – net | $6.6B | $6.7B | $7.0B | $7.1B |
| Regulatory assets, deferred charges, and other | $2.0B | $1.9B | $1.9B | $1.8B |
| Total assets | $60.6B | $59.6B | $55.7B | $56.1B |
| Accounts payable | $2.2B | $2.3B | $1.4B | $1.4B |
| Liabilities held for sale (Note 3) | $9.0M | $0 | — | — |
| Derivative Liability, Current | $127.0M | $174.0M | $101.0M | $108.0M |
| Other current liabilities | $1.5B | $1.3B | $1.5B | $1.5B |
| Commercial paper | $475.0M | $0 | $170.0M | $0 |
| Long-term debt due within one year | $2.2B | $248.0M | $2.2B | $3.0B |
| Total current liabilities | $6.5B | $4.0B | $5.4B | $6.0B |
| Long-term debt | $28.1B | $30.1B | $25.6B | $25.6B |
| Deferred income tax liabilities | $5.6B | $5.4B | $4.8B | $4.6B |
| Other Liabilities, Noncurrent | $296.0M | $229.0M | $259.0M | $265.0M |
| Regulatory liabilities, deferred income, and other | $5.0B | $4.9B | $5.1B | $5.2B |
| Preferred stock ($1 par value; 30 million shares authorized at June 30, 2026 and December 31, 2025; 35 thousand shares issued at June 30, 2026 and December 31, 2025) | 35.0M | 35.0M | 35.0M | 35.0M |
| Common stock ($1 par value; 1,470 million shares authorized at June 30, 2026 and December 31, 2025; 1,262 million shares issued at June 30, 2026 and 1,261 million shares issued at December 31, 2025) | 1.3B | 1.3B | 1.3B | 1.3B |
| Capital in excess of par value | $24.8B | $24.8B | $24.7B | $24.6B |
| Retained deficit | ($11.8B) | ($12.0B) | ($12.4B) | ($12.4B) |
| Accumulated other comprehensive income (loss) | $124.0M | $125.0M | $102.0M | $77.0M |
| Treasury stock, at cost (39 million shares at June 30, 2026 and December 31, 2025 of common stock) | -1.2B | -1.2B | -1.2B | -1.2B |
| Total stockholders’ equity | $13.2B | $13.0B | $12.5B | $12.4B |
| Noncontrolling interests in consolidated subsidiaries | $2.2B | $2.2B | $2.3B | $2.4B |
| Total equity | $15.4B | $15.2B | $14.9B | $14.8B |
| Total liabilities and equity | $60.6B | $59.6B | $55.7B | $56.1B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net income (loss) | $2.8B | $2.3B | $3.3B | $2.1B |
| Depreciation, depletion, and amortization | $2.3B | $2.2B | $2.1B | $2.0B |
| Provision (benefit) for deferred income taxes | $744.0M | $506.0M | $951.0M | $431.0M |
| Equity (earnings) losses | ($760.0M) | ($560.0M) | ($589.0M) | ($637.0M) |
| Distributions from equity-method investees (Note 8) | $800.0M | $789.0M | $796.0M | $865.0M |
| Other Asset Impairment Charges | $212.0M | — | — | $0 |
| Net unrealized (gain) loss from commodity derivative instruments | ($150.0M) | $367.0M | ($660.0M) | $249.0M |
| Gain on sale of business (Note 3) | $0 | $0 | ($129.0M) | — |
| Gain on disposition of equity-method investments (Note 8) | $0 | ($149.0M) | — | — |
| Gain on remeasurement of equity-method investments (Note 3) | $0 | ($127.0M) | — | — |
| Inventory write-downs | $8.0M | $10.0M | $30.0M | $161.0M |
| Amortization of stock-based awards | $93.0M | $99.0M | $77.0M | $73.0M |
| Accounts receivable | ($219.0M) | ($169.0M) | $1.1B | ($733.0M) |
| Inventories | ($45.0M) | ($9.0M) | $13.0M | ($110.0M) |
| Other current assets and deferred charges | ($71.0M) | $9.0M | $60.0M | ($33.0M) |
| Accounts payable | $115.0M | $139.0M | ($1.0B) | $410.0M |
| Other current liabilities | $170.0M | $35.0M | — | — |
| Changes in current and noncurrent commodity derivative assets and liabilities | $99.0M | ($286.0M) | $200.0M | $94.0M |
| Other, including changes in noncurrent assets and liabilities | ($213.0M) | ($245.0M) | ($246.0M) | ($216.0M) |
| Net cash provided (used) by operating activities | $5.9B | $5.0B | $5.9B | $4.9B |
| Proceeds from (payments of) commercial paper – net | $245.0M | ($269.0M) | $372.0M | $345.0M |
| Proceeds from long-term debt | $4.9B | $3.6B | $2.8B | $1.8B |
| Payments of long-term debt | ($2.8B) | ($2.9B) | ($634.0M) | ($2.9B) |
| Payments for debt issuance costs | ($45.0M) | ($32.0M) | ($23.0M) | ($17.0M) |
| Proceeds from issuance of common stock | $9.0M | $10.0M | $6.0M | $54.0M |
| Purchases of treasury stock | $0 | $0 | ($130.0M) | — |
| Common dividends paid | ($2.4B) | ($2.3B) | ($2.2B) | ($2.1B) |
| Dividends and distributions paid to noncontrolling interests | ($259.0M) | ($242.0M) | ($213.0M) | ($204.0M) |
| Contributions from noncontrolling interests | $36.0M | $36.0M | $18.0M | $18.0M |
| Other – net | ($63.0M) | ($36.0M) | ($21.0M) | ($46.0M) |
| Net cash provided (used) by financing activities | ($406.0M) | ($2.2B) | ($49.0M) | ($3.0B) |
| Capital expenditures (1) | ($4.9B) | ($2.6B) | ($2.5B) | ($2.3B) |
| Dispositions – net | ($106.0M) | ($105.0M) | ($51.0M) | ($30.0M) |
| Proceeds from sale of business (Note 3) | $0 | $0 | $346.0M | — |
| Purchases of businesses, net of cash acquired (Note 3) | ($1.0M) | ($2.2B) | ($1.6B) | ($933.0M) |
| Proceeds from dispositions of equity-method investments (Note 8) | $0 | $161.0M | — | — |
| Purchases of and contributions to equity-method investments (Note 8) | ($511.0M) | ($114.0M) | ($141.0M) | ($166.0M) |
| Other – net | $22.0M | $12.0M | $39.0M | ($5.0M) |
| Net cash provided (used) by investing activities | ($5.5B) | ($4.9B) | ($3.9B) | ($3.4B) |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total | $3.0M | ($2.1B) | $2.0B | ($1.5B) |
| Cash and cash equivalents at beginning of year | $60.0M | $2.1B | $152.0M | $1.7B |
| Cash and cash equivalents at end of year | $63.0M | $60.0M | $2.1B | $152.0M |
| (1) Increases to property, plant, and equipment | ($5.4B) | ($2.6B) | ($2.6B) | ($2.4B) |
| Changes in related accounts payable and accrued liabilities | $482.0M | $8.0M | $48.0M | $141.0M |
| Capital expenditures | ($4.9B) | ($2.6B) | ($2.5B) | ($2.3B) |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net income (loss) | $1.8B | $912.0M | $2.0B | $1.3B |
| Depreciation, depletion, and amortization | $1.2B | $584.0M | $1.8B | $1.2B |
| Provision (benefit) for deferred income taxes | $492.0M | $235.0M | $442.0M | $186.0M |
| Equity (earnings) losses | ($320.0M) | ($161.0M) | ($449.0M) | ($297.0M) |
| Distributions from equity-method investees | $448.0M | $223.0M | $600.0M | $412.0M |
| Gain on sale of certain assets (Note 3) | ($194.0M) | ($182.0M) | — | — |
| Net unrealized (gain) loss from commodity derivative instruments | $83.0M | $225.0M | ($55.0M) | ($4.0M) |
| Gain on disposition of equity-method investments (Note 3) | ($127.0M) | — | $0 | — |
| Inventory write-downs | $12.0M | $2.0M | $5.0M | $4.0M |
| Amortization of stock-based awards | $39.0M | $22.0M | $70.0M | $49.0M |
| Accounts receivable | $106.0M | $425.0M | $384.0M | $301.0M |
| Inventories | ($32.0M) | $50.0M | ($66.0M) | ($61.0M) |
| Other current assets and deferred charges | ($23.0M) | ($9.0M) | ($43.0M) | ($36.0M) |
| Accounts payable | ($240.0M) | ($194.0M) | ($359.0M) | ($265.0M) |
| Other current liabilities | ($58.0M) | ($317.0M) | $95.0M | $150.0M |
| Changes in current and noncurrent commodity derivative assets and liabilities | ($56.0M) | ($138.0M) | $77.0M | $19.0M |
| Other, including changes in noncurrent assets and liabilities | ($115.0M) | ($74.0M) | ($128.0M) | ($77.0M) |
| Net cash provided (used) by operating activities | $3.0B | $1.6B | $4.3B | $2.9B |
| Proceeds from (payments of) commercial paper – net | ($224.0M) | ($699.0M) | ($284.0M) | ($454.0M) |
| Proceeds from long-term debt | $2.8B | $2.8B | $3.0B | $3.0B |
| Payments of long-term debt | ($1.1B) | ($1.1B) | ($1.7B) | ($975.0M) |
| Payments for debt issuance costs | ($33.0M) | ($24.0M) | ($29.0M) | ($26.0M) |
| Proceeds from issuance of common stock | $8.0M | $8.0M | $9.0M | $5.0M |
| Common dividends paid | ($1.3B) | ($642.0M) | ($1.8B) | ($1.2B) |
| Dividends and distributions paid to noncontrolling interests | ($140.0M) | ($67.0M) | ($197.0M) | ($131.0M) |
| Contributions from noncontrolling interests | $32.0M | $0 | $22.0M | $19.0M |
| Other – net | ($79.0M) | ($67.0M) | ($60.0M) | ($57.0M) |
| Net cash provided (used) by financing activities | ($49.0M) | $168.0M | ($1.1B) | $154.0M |
| Capital expenditures (1) | ($3.2B) | ($1.4B) | ($2.9B) | ($2.0B) |
| Dispositions – net (Note 3) | $345.0M | $369.0M | ($80.0M) | ($40.0M) |
| Proceeds from sale of business (Note 7) | $48.0M | $48.0M | — | — |
| Proceeds from disposition of equity-method investments (Note 3) | $6.0M | — | $0 | — |
| Purchases of and contributions to equity-method investments | ($91.0M) | ($29.0M) | ($192.0M) | ($179.0M) |
| Other – net | $95.0M | $87.0M | $9.0M | $10.0M |
| Net cash provided (used) by investing activities | ($2.8B) | ($884.0M) | ($3.2B) | ($2.2B) |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total | $140.0M | $887.0M | $10.0M | $843.0M |
| Cash and cash equivalents at beginning of year | $63.0M | $63.0M | $60.0M | $60.0M |
| Cash and cash equivalents at end of period | $203.0M | $950.0M | $70.0M | $903.0M |
| (1) Increases to property, plant, and equipment | ($3.3B) | ($1.6B) | ($3.1B) | ($2.0B) |
| Changes in related accounts payable and accrued liabilities | $154.0M | $234.0M | $141.0M | $57.0M |
| Capital expenditures | ($3.2B) | ($1.4B) | ($2.9B) | ($2.0B) |
Williams Cos Inc score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.